25/03/2026
๐๐ฒ๐๐ผ๐๐ต๐ผ ๐ฟ๐ฎ๐น๐น๐ถ๐ฒ๐ ๐ฎ๐ด๐ฎ๐ถ๐ป๐๐ ๐๐๐ฏ๐ฒ๐ฟ๐ฐ๐๐น๐ผ๐๐ถ๐ ๐๐ถ๐๐ต ๐ฐ๐ผ๐บ๐บ๐๐ป๐ถ๐๐-๐น๐ฒ๐ฑ ๐๐ฐ๐ฟ๐ฒ๐ฒ๐ป๐ถ๐ป๐ด ๐ฐ๐ฎ๐บ๐ฝ๐ฎ๐ถ๐ด๐ป๐
To mark World TB Day, the World Health Organization supported the Ministry of Health in launching rapid, community-led tuberculosis (TB) screening campaigns across all districts. Guided by the global theme โYes! We Can End TB: Led by countries, powered by people,โ the initiative brought residents together for free testing, reinforcing the nationโs commitment to early detection, treatment, and reducing TB-related morbidity and mortality.
At St Andrews Health Centre in Mafeteng and other facilities nationwide, health workers carried out community mobilization and sensitization exercises, encouraging people to come forward for free screening. A public health nurse at the Mafeteng centre, Lepolesa Mpholo, emphasized the importance of the activity, noting that screenings are vital in reducing transmission and protecting families. โThis service is free, and we encourage everyone to take part so that no one is left behind in the fight against TB,โ he said.
The World Health Organization (WHO) has called for urgent action to accelerate TB control, spotlighting new diagnostic innovations that promise faster, cheaper, and more accessible testing. These include portable, battery-powered devices that deliver results in under an hour, tongue swab sampling for patients unable to produce sputum, and sputum pooling strategies that reduce costs and increase efficiency.
The WHO Regional Director for Africa, Dr Mohamed Yakub Janabi, highlighted the significant progress already made in the region: โBetween 2015 and 2024, TB deaths declined by 46%, and TB incidence fell by 28%. Several countries have reached key global milestones: South Africa met the 2025 target for reducing TB incidence, while Mozambique, Tanzania, Togo, and Zambia achieved a 75% reduction in TB deaths.โ
He further noted the impact of new treatments: โRapid diagnostic technologies are being scaled up, and shorter, more effective six-month all-oral treatment regimens are transforming outcomes for people with drug-resistant TB. The revolutionary six-month all-oral BPaLM regimen has achieved success rates exceeding 85%, with the African Region leading the global uptake. Between 2023 and 2024, the proportion of drug-resistant patients receiving six-month regimens surged from almost zero to about 40%, the fastest adoption rate of any WHO region. This progress demonstrates that determined leadership, strengthened health systems, and community engagement can deliver measurable results.โ
TB remains one of the worldโs deadliest infectious diseases, claiming more than 3,300 lives daily. While global efforts have saved an estimated 83 million lives since 2000, WHO warns that funding cuts and slow uptake of rapid diagnostics threaten progress.
Lesothoโs grassroots efforts, such as the community-led TB screening, reflect the countryโs determination to confront TB head-on. WHO continues to urge governments worldwide to prioritize TB as a central pillar of health security and universal health coverage, while also investing in research and innovation, including vaccine development through the TB Vaccine Accelerator Council.